Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001885810 | SCV002143366 | uncertain significance | Brugada syndrome 7 | 2024-12-30 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 36 of the SCN3B protein (p.Val36Met). This variant is present in population databases (rs147803210, gnomAD 0.02%). This missense change has been observed in individual(s) with sudden unexplained death (PMID: 20226894). ClinVar contains an entry for this variant (Variation ID: 1376285). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SCN3B function (PMID: 20226894). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001885810 | SCV002775680 | uncertain significance | Brugada syndrome 7 | 2021-09-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003164240 | SCV003858664 | likely benign | Cardiovascular phenotype | 2023-03-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |